Autonomic neuropathy improves with disease modifying anti rheumatic drugs
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: SYNGLE, Ashit (Healing Touch City Clinic; Fortis, Int Medicine, Chandigarh, India)
- Co-author(s): Verma, Inderjeet (Punjabi University, Patiala, India)
Krishan, Pawan (Punjabi University, Patiala, India)
Garg, Nidhi (Punjabi University, Patiala, India)
Background: Cardiovascular autonomic neuropathy (CAN) is a significant risk predictor of sudden cardiac death in rheumatic diseases. However, no treatment strategy has been investigated to CAN.
Objective: To determine the efficacy of DMARDs on autonomic neuropathy (AN) in rheumatoid arthritis (RA) and ankylosing spondylitis (AS).
Methods- We.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.